In the prostate cancer, the IL-6–STAT3 signal path is involved in protecting against tumor progression via maintaining an intact senescence-inducing ARF–MDM2–p53 tumor suppressor axi [17]. The gene discussed is CDKN2A; the disease is Familial prostate cancer.